News Medical on MSN54m
Vision loss risks in patients using popular GLP-1 medications raise concerns
A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
AbbVie gets FDA approval for antibiotic treatment Emblaveo (update)
AbbVie (ABBV) said it has received FDA approval for the combination antibiotic treatment Emblaveo, which was co-developed ...
ConsumerAffairs15h
Here are the health pros and cons of GLP-1RA weight loss drugs
New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...
Crain's Chicago Business7h
AbbVie gets FDA OK on antibiotic therapy that fights resistant bacteria
It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.
News Medical on MSN16h
Opioid δ-receptor agonists show promise for treating IBS-like symptoms
Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...
AbbVie gets FDA approval for antibiotic treatment Emblaveo
AbbVie (NYSE:ABBV) said it has received FDA approval for its intravenous antibiotic treatment Emblaveo. The FDA approved Emblaveo, a combination of aztreonam and avibactam, for use in combination with ...